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Abstract
Metabolic alterations are associated with arthritis apart from obesity. However, it is still
unclear which is the underlying process behind these metabolic changes. Here, we investi-
gate the role of tumor necrosis factor (TNF) in this process in an acute model of antigen-
induced arthritis (AIA). Immunized male BALB/c mice received an intra-articular injection of
PBS (control) or methylated bovine serum albumin (mBSA) into their knees, and were also
pre-treated with different drugs: Etanercept, an anti-TNF drug, DF2156A, a CXCR1/2 recep-
tor antagonist, or a monoclonal antibody RB6-8C5 to deplete neutrophils. Local challenge
with mBSA evoked an acute neutrophil influx into the knee joint, and enhanced the joint
nociception, along with a transient systemic metabolic alteration (higher levels of glucose
and lipids, and altered adipocytokines). Pre-treatment with the conventional biological Eta-
nercept, an inhibitor of TNF action, ameliorated the nociception and the acute joint inflam-
mation dominated by neutrophils, and markedly improved many of the altered systemic
metabolites (glucose and lipids), adipocytokines and PTX3. However, the lessening of met-
abolic changes was not due to diminished accumulation of neutrophils in the joint by Etaner-
cept. Reduction of neutrophil recruitment by pre-treating AIA mice with DF2156A, or even
the depletion of these cells by using RB6-8C5 reduced all of the inflammatory parameters
and hypernociception developed after AIA challenge, but could not prevent the metabolic
changes. Therefore, the induction of joint inflammation provoked acute metabolic alter-
ations which were involved with TNF. We suggest that the role of TNF in arthritis-associated
metabolic changes is not due to local neutrophils, which are the major cells present in this
model, but rather due to cytokines.
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Introduction
Systemic metabolic alterations are not only caused by obesity and their associated comorbidi-
ties, but also linked to autoimmune diseases such as arthritis [1]. Arthritis is characterized by
an infiltration of inflammatory cells, cartilage and bone destruction, and it is clinically pre-
sented as pain, swelling and stiffness of affected joints [2]. Inflammatory cytokines and
chemokines play a pivotal role in the local and systemic inflammation of arthritic patients, con-
tributing to the disease development and progression [3]. Despite it is not well explored, neu-
trophils also participate in arthritis progression, and evidences indicate that neutrophil influx
does occur during recurrence of disease [4]. Moreover, lean patients diagnosed with arthritis
have shown alterations in serum levels of adipocytokines, which are released mainly from the
adipose tissue and are also associated with arthritis progression [5].
Different categories of drugs are routinely used for the treatment of arthritis, aiming to
relieve symptoms and avoid progression of the disease [6]. Although some components of the
arthritic inflammatory response still need to be unveiled, there have been significant develop-
ments in the last decades, including novel immunobiological agents targeting tumor necrosis
factor (TNF). In addition to providing relief to patients, these agents have been shown to
improve metabolic alterations associated with arthritis [7, 8]. However, mechanisms describing
the relationship among soluble mediators and systemic metabolic alterations still need to be
elucidated.
We have previously described a local production of TNF-α and chemokine (C-X-C motif)
receptor 2 (CXCR2)-mediated neutrophil influx following antigen challenge in a model of anti-
gen-induced arthritis (AIA) in mice [9, 10]. Here, we report that there is also a systemic meta-
bolic alteration after acute induction of AIA. We then investigated the relative contribution
of TNF for the observed systemic metabolic changes, and which is the relation to its known
inflammatory role.
Materials and Methods
Ethical Approval
All experiments with mice were approved by the “Ethics Committee in Animal Experimenta-
tion at Universidade Federal de Minas Gerais” in Brazil (protocol: 148/2012).
Animals
Eight-week-old male BALB/c mice were obtained from the animal care center at Universidade
Federal de Minas Gerais. It was also used mice with a lysozyme M promoter for enhanced
green fluorescent protein (LysM-eGFP), expressing fluorescently neutrophils for the confocal
microscopy analysis. They were maintained in an environmentally controlled room under a
12/12 h light-dark cycle, with filtered water and food ad libitum. During the procedures for
arthritis induction, mice were anesthetized with 1.5% isoflurane in oxygen. After the indicated
time points, mice were anesthetized with ketamine (80 mg/kg) and xylazine (10 mg/kg) and
killed. Samples of the blood, knee, epididymal adipose tissue and liver were collected for further
analysis.
Arthritis induction and assessment of articular inflammation
Mice were immunized i.d. at the base of the tail with 500 μg of methylated BSA (mBSA) in
100 μL of an emulsion containing saline and an equal volume of complete Freund’s adjuvant.
The knee challenge was performed 14 days later. For the control group, each mouse received
an intra-articular injection in both knee joints with 10 μL PBS. This group is represented by the
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mean of all time points evaluated. For AIA mice, they were injected with 10 μg mBSA in 10 μL
PBS [9]. After the antigen challenge, mice were killed at the indicated time points. The knee
cavity was washed with PBS (2x 5 μL) for cell recovery. The total number of leukocytes was
determined by counting leukocytes in the synovial fluid by manual counting using Neubauer
chamber under optical microscopy after staining with Turk’s solution. Differential counts were
obtained from cytospin preparations (Shandon III, Thermo Shandon, Frankfurt, Germany)
stained with May—Grünwald—Giemsa. The peri-articular tissue was removed for determina-
tion of myeloperoxidase activity and cytokine/chemokine measurement by ELISA.
Drugs
Etanercept (Enbrel1) was diluted in saline and administered i.p. (10 mg/kg) in a volume of
100 μL 30 min before the arthritis induction. The allosteric CXCR1/2 inhibitor DF2156A (10
mg/kg) was diluted in carboxymethylcellulose 0.5% and given orally per gavage 30 min
before arthritis challenge (Biogen-Dompé, Italy). Anti-GR-1 MAb (RB6-8C5 clone) was
injected i.v. (1 mg/mL) in a volume of 100 μL twice, one day and 1 hour before arthritis induc-
tion (eBioscience, San Diego, CA). Control PBS and AIA groups received the same vehicle and
administration route of the drug correspondent in each experiment.
Nociception assessment
In a quiet room, the mice were placed in acrylic cages (12x10x17 cm high) with a wire grid
floor, 15–30 min before the test, for environmental adaptation. A series of stimuli was per-
formed only when the animals were quiet, without exploratory movements or defecation. In
these experiments, an electronic pressure meter was used. It consists of a hand-held force trans-
ducer fitted with a polypropylene tip (INSIGHT Instruments, Ribeirão Preto, São Paulo, Brazil)
[11]. A non-standard large tip (4.15 mm2) was adapted to the probe [12]. An increasing per-
pendicular force was applied to the central area of the plantar surface of the hind paw to induce
the flexion of the knee joint, followed by paw withdrawal. A tilted mirror below the grid pro-
vided a clear view of the animal’s hind paw. The end point was characterized by the removal of
the paw from the polypropylene tip. After the flexion-elicited withdrawal threshold, the inten-
sity of the pressure was automatically recorded. The value for the response was obtained by
averaging two measurements in one hind paw.
Total and differential blood cell counts
Blood was collected from the tail vein of mice and the total white blood cells were counted
using a Neubauer chamber. Peripheral blood smears were stained with May-Grünwald-
Giemsa, and the differential white blood cell count was determined under oil immersion
(1000x).
Histology
The knee joint was removed and fixed for 24 h with 4% a neutral-buffered formalin. Then, the
joints were incubated in 14% EDTA at pH 7.2 during 4 weeks at room temperature for decalci-
fication. The samples were embedded in paraffin and sections of 7 mm were stained with
Hematoxilin-eosin. Two sections/knee joint were microscopically examined and scored in a
blind manner for different parameters [13], as follows: severity of synovial hyperplasia (ranging
from 0 to 3) and intensity and extension of inflammatory infiltrate (ranging from 0 to 4). The
grades were summed to obtain an arthritis index (ranging from 0 to 7).
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Confocal Microscopy
Immunized LysM-eGFP mice (eGFP-expressing neutrophils) were challenge with a knee injec-
tion of PBS or mBSA and after 3 and 24 hours the confocal microscopy was performed as
described before [14]. Briefly, mice were anesthetized with ketamine (80 mg/kg) and xylazine
(10 mg/kg). Epididymal adipose tissue and liver were exposed over a Plexiglas support, and
the tissue microcirculation was visualized under confocal microscopy using an Olympus Fluo-
view FV300 laser-scanning microscope equipped with a 488 nm argon laser. All images were
acquired using a 10x magnification objective lens, and three different fields from each mouse
were analyzed.
Oral glucose tolerance test (OGTT)
After 24 hours of PBS or mBSA knee injection, mice were fasted overnight and received D-glu-
cose (2 mg/g body weight) orally per gavage. Levels of glucose were measured from the blood
collected from the tip of the tail at 0, 15, 30, 60, and 90 min after D-glucose administration
using a glucometer (Accu-Check, Roche Diagnostics, Indianapolis, IN).
Metabolic analyses in the serum
Total cholesterol, triglyceride and glucose levels were quantified by enzymatic kits (KATAL,
Belo Horizonte, MG, Brazil). Adiponectin, resistin and leptin levels were assayed by ELISA
(R&D systems Europe Ltd., Abington, UK) as well as insulin (Millipore, Bedford, MA). The
insulin resistance index was calculated as follows: HOMA-IR = fasting glucose level (mmol/L)
x fasting insulin level (μU/mL) 22.5.
ELISA assay
Samples of peri-articular tissue, epididymal adipose tissue and liver were homogenized with a
protease inhibitor solution (1:10). This solution contained 0.4 M NaCl, 0.05% Tween 20, 0.5%
bovine serum albumin, 0.1 mM fluoride fenilmetilsufonila, 0.1 mM benzethonium chloride, 10
mM EDTA, 20 IU of aprotinin diluted in a solution of phosphate buffer (8g NaCl, 0.2g KCl
and 2.89 g Na2HPO4.12H2O diluted in 1 liter of distilled water). The homogenate was centri-
fuged at 10,000 rpm for 10 minutes at 4°C and the supernatant of knee and liver, and the infra-
natant of adipose tissue were collected to measure cytokine/chemokine levels by ELISA. Levels
of chemokine (C-X-C motif) ligand 1 (CXCL1) were determined in the peri-articular tissue,
epididymal adipose tissue and liver, and pentraxin 3 (PTX3) was evaluated in the serum
using DuoSet ELISA development kits (R&D System, Inc., Minneapolis, MN, USA), in which
cytokines are detected using a sandwich antibody system according to the manufacturer’s
instructions.
Myeloperoxidase (MPO) activity
Indirect neutrophil presence was measured by assaying MPO activity, as described previously
[15]. Briefly, peri-articular tissue, epididymal adipose tissue and liver samples of mice were
homogenized and assayed for MPO activity by measuring the change in OD at 450 nm using
tetramethylbenzidine.
Leukocyte analysis by flow cytometry
After blood collection (0.1 ml), the red blood cells were lysed with ACK buffer. Subsequently,
cells were incubated with the specific monoclonal antibody for markers of the main cellular
populations present in the peripheral blood, GR1 and CD11b (neutrophils), CD3 (T cells) and
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F4/80 (monocytes) (BD Pharmingen). Cells were analyzed with a FACSCalibur CantoII, and
data were analyzed by FlowJo (TreeStar).
Statistical analysis
Data are expressed as mean ± SEM. Multiple comparisons were performed using one-way
ANOVA: it was used the Dunnett’s post-hoc test in the kinetic results; for experiments with
drugs the Newman-Keuls post-hoc analysis and; in the OGTT two-way ANOVA followed by
the Bonferroni post-hoc test. The statistical analysis was performed using the software Graph-
Pad Prism (GraphPad Software, La Jolla, CA). The statistical significance was set at P<0.05.
Results
Acute arthritis induces accumulation of neutrophils in the adipose tissue
and liver, and triggers metabolic alterations
At 24 and 48 hours after AIA induction, mice had a significant hypernociception, which is an
index of pain, as assessed by the lower paw withdrawal threshold compared with control mice
(Fig 1A). This acute phase of AIA was also characterized by an increased recruitment of neu-
trophils into the knee joint and peri-articular tissue (MPO activity), which peaks at 24 hours
after challenge (Fig 1B and 1C). Neutrophil accumulation in the synovial fluid resolved at 48
hours, but it was still present at this time in the peri-articular tissue. The recruitment of neutro-
phils was mirrored by the presence of the neutrophil-active chemokine CXCL1 in the peri-
articular tissue (Fig 1D). Histopathological analysis showed an intense infiltration of neutro-
phils and increased synovial hyperplasia (Fig 1E and 1F). There was also an increase in MPO
activity in the epididymal adipose tissue and liver, suggesting a significant influx of neutrophils
in these two organs (Fig 1G). Despite this increase in neutrophil infiltration, we did not observe
alterations in the levels of CXCL1 chemokine in the adipose tissue, but only in the liver at 1, 3
and 48 hours after AIA challenge (Fig 1H). Using Lysm-eGFP mice, which present eGFP-
expressing neutrophils, we showed an increase in the neutrophil accumulation in the adipose
tissue at 24 hours and in the liver at 3 and 24 hours following arthritis induction (Fig 1I and
1J), concurring with the MPO data.
In order to verify whether the metabolism of mice was affected when subjected to AIA, we
evaluated the major systemic metabolic parameters after antigen administration in the joint
of immunized mice. AIA mice showed alterations in the glucose and lipid metabolism, as seen
by an acute hyperglycemia, insulin resistance, glucose intolerance, hypertriglyceridemia and
increased cholesterol levels (Fig 2A–2E). The adipocytokines, which are released mainly by adi-
pose tissue, were also altered in AIA mice. Levels of adiponectin reduced while levels of leptin
increased in specific time points (Fig 2F and 2G). There were no changes in resistin levels (data
not shown). Altogether, these results demonstrate that mice challenged with a local antigen-
specific inflammatory stimulus had significant systemic metabolic changes.
The metabolic changes in AIA mice are dependent of TNF
The blockade of TNF may prevent the inflammatory response and hypernociception in this
model of AIA [10]. To evaluate the relevance of TNF in the systemic metabolic changes
observed after induction of AIA, mice were treated with Etanercept, a known TNF inhibitor in
humans and mice [16, 17]. The pre-treatment with Etanercept reduced all the inflammatory
parameters developed after AIA challenge (Fig 3A–3E). Interestingly, glucose and lipid
parameters were also improved (Fig 3F–3I), and serum levels of adiponectin and leptin were
normalized in mice treated with Etanercept (Fig 3J). PTX3 is a serum reactive protein rapidly
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Fig 1. Antigen-induced arthritis in mice is mainly associated with the presence of neutrophils. (A) Intensity of nociception. (B) Number of neutrophils,
(C) myeloperoxidase activity, and (D) CXCL1 chemokine levels in the peri-articular tissue. (E) Representative photos of the morphologic alterations in the
knee (x100 and x400) and (F) arthritis index. Arrows indicate the synovial and asterisks represent the inflammatory infiltrate. Adipose tissue and liver (G)
myeloperoxidase activity, and (H) CXCL1 levels at 1, 3, 24 and 48 hours after the challenge with the antigen-induced arthritis (AIA). Bars represent the mean
values±SEM (n = 6–8). Neutrophils number in (I) epididymal adipose tissue and liver accumulated in Lysm-eGFPmice and (J) representative confocal
microscopy image, 3 and 24 hours after the challenge with the AIA (x100). Bars represent the mean values±SEM (n = 3–5), *P<0.05 vs. PBS.
doi:10.1371/journal.pone.0146403.g001
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produced during inflammatory responses [18]. Interestingly, Etanercept also prevented the
increase in PTX3 levels observed after induction of AIA (Fig 3K). Therefore, TNF appears to
represent an important component for the altered systemic metabolic parameters in this model
of AIA.
Although neutrophils are infiltrated into the adipose tissue and liver, they
do not appear to alter metabolic parameters induced by AIA
The inflammatory response developed in this model of arthritis is characterized by marked
neutrophil influx, neutrophil-dependent joint damage and dysfunction [9]. Next, we investi-
gated whether neutrophils, which were reduced by Etanercept, could contribute to the meta-
bolic changes observed in AIA mice. Mice pre-treated with DF2156A, a CXCR1/2 receptor
antagonist, showed reduced intensity of nociception, neutrophil accumulation into the knee
joint and in the peri-articular tissue following AIA challenge (Fig 4A–4C), although no alter-
ations in the CXCL1 levels were found (Fig 4D). Joint damage, as assessed histologically was
also improved in DF2156A-treated mice (Fig 4E). However, the treatment with DF2156A did
not alter changes in glucose levels and HOMA-IR induced by AIA (Fig 4F and 4G), and actu-
ally, the glucose intolerance worsened (Fig 4H). Similarly, treatment with DF2156A tended to
enhance further the levels of triglycerides and total cholesterol (24 hours) (Fig 4I). Levels of
adiponectin were further enhanced at 24 hours by the treatment with DF2156A whereas levels
of leptin were similarly increased in DF2156A and vehicle-treated animals (Fig 4J). It was
Fig 2. Systemic metabolic alterations in antigen-induced arthritis mice at different time points. The metabolism of glucose showed by (A) glucose
levels, (B) HOMA-IR index and (C) oral glucose tolerance test. The lipid metabolism represented by (D) triglyceride and (E) total cholesterol levels. Serum
levels of the adipocytokines, (F) adiponectin and (G) leptin at 1, 3, 24 and 48 hours after the challenge with the antigen-induced arthritis (AIA). The bars
represent the mean values ± SEM (n = 6–8), *P<0.05 vs. PBS.
doi:10.1371/journal.pone.0146403.g002
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observed increased PTX3 levels in AIA mice, especially 24 hours after challenge. The treat-
ment with DF2156A induced a further increase in PTX3 levels at both time points evaluated
(Fig 4K).
In other to better investigate the role of neutrophils in the systemic metabolic alterations
observed in AIA mice, we used the monoclonal antibody RB6-8C5 (anti-GR-1) to deplete neu-
trophils. We confirmed the depletion of neutrophils in these mice by flow cytometry and differ-
ential leukocyte count in the blood (S1 Fig), with no alteration on the absolute amount of
lymphocytes or monocytes (data not shown). The depletion was also This treatment was effec-
tive in reducing hypernociception (Fig 5A). Corroborating with the efficacy of neutrophils
depletion, we did not observe increased neutrophil accumulation into the knee joint or in the
peri-articular tissue in RB6-8C5-treated mice after AIA induction (Fig 5B and 5C). Analyses of
systemic metabolism showed a similar profile to that seen in DF2156A-treated mice. Again,
Fig 3. Pre-treatment with Etanercept improves the alteredmetabolic parameters of antigen-induced arthritis mice. (A) Intensity of nociception. (B)
Neutrophils, (C) myeloperoxidase activity, (D) CXCL1 chemokine in the peri-articular tissue and (E) arthritis index. Systemic glucose metabolism showed by
(F) glucose levels, (G) HOMA-IR index and (H) oral glucose tolerance test. The lipids, (I) triglyceride and total cholesterol levels. The adipocytokines, (J)
adiponectin and leptin levels. (K) PTX3 levels of mice that received a knee intra-articular injection of PBS, mBSA or mBSA treated prior with Etanercept. Bars
represent the mean values ±SEM (n = 6–8), *P<0.05 vs. PBS; #P<0.05 vs. AIA of the respective time.
doi:10.1371/journal.pone.0146403.g003
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the neutrophil depletion did not prevent the metabolic dysfunction induced by arthritis. There
was no alteration on glucose levels in neutrophil-depleted mice compared with AIA groups
(Fig 5D). Moreover, triglyceride and cholesterol levels increased further in neutrophil-depleted
mice 3 hours after challenge (Fig 5E). Levels of adiponectin reduced at 24 hours and leptin
increased further (Fig 5F) in neutrophil-depleted mice compared with AIA control mice. As
observed in DF2156A-treated mice, levels of PTX3 tended to be higher after neutrophil deple-
tion than in control AIA mice (Fig 5G). These observations suggest that the metabolic dysfunc-
tion in this model of AIA is not associated with the influx of neutrophils. On the contrary,
blockade of neutrophil influx or depletion of neutrophils was associated with a mild worsening
of systemic metabolic parameters.
Fig 4. Pre-treatment with DF2156A contributes to metabolic alterations in antigen-induced arthritis mice. (A) Intensity of nociception. (B) Number of
neutrophils, (C) myeloperoxidase activity, (D) CXCL1 chemokine in the peri-articular tissue and (E) arthritis index. Systemic glucose metabolism showed by
(F) glucose levels, (G) HOMA-IR index and (H) oral glucose tolerance test. The lipids, (I) triglyceride and total cholesterol levels. The adipocytokines, (J)
adiponectin and leptin levels. (K) PTX3 levels of mice that received a knee intra-articular injection of PBS, mBSA or mBSA treated prior with DF2156A. Bars
represent the mean values±SEM (n = 6–8), *P<0.05 vs. PBS; #P<0.05 vs. AIA of the respective time.
doi:10.1371/journal.pone.0146403.g004
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Discussion
Arthritis is frequently associated with metabolic dysfunction, which may be a consequence of
the systemic inflammatory response of this disease [5, 19]. Herein, we have shown that the
acute model of AIA transiently alters the metabolism of mice, as observed by higher glucose
and lipid levels, altered adipocytokine production and by the increase in neutrophil infiltration
into the adipose tissue and liver. TNF appears to be an important mediator of the metabolic
changes in AIA mice. The investigation of the mechanisms that lead to metabolic alterations
ruled out an important participation of the neutrophils, the main cell type involved in the
inflammatory response in this model.
The metabolic syndrome is a risk factor for patients with rheumatoid arthritis (RA) [1] and
the cause of this dysfunction is still unclear. Some studies have demonstrated that RA patients
present alterations in the glucose and lipid metabolism, including insulin resistance, high levels
of cholesterol and hypertriglyceridemia in the absence of obesity [20, 21]. Indeed, we have
shown that transient metabolic changes may occur even in lean mice during acute arthritis
induction. The inflammation is known to induce an increase in the metabolic demand [22].
This increase appears to be transient, but necessary to provide the appropriate fuel for an acute
inflammatory response and subsequent recover to homeostasis. The inflammation observed in
the adipose tissue and liver may also trigger the mobilization and systemic release of nutrients,
as demonstrated in other acute inflammatory processes [23, 24]. It is also described that the
intermediated metabolism (gluconeogenesis and lipolysis) is activated during the process of
stress [25], leading to increase in lipids and glucose in the circulation [26, 27]. Moreover, the
alteration of these parameters may be a consequence of systemic inflammation [28] and be
involved with pain, which is often observed in patients with arthritis [29]. Acute pain by itself
Fig 5. Depletion of neutrophils did not improve the metabolic alterations in antigen-induced arthritis mice. (A) Intensity of nociception. Inflammation
in the knee cavity represented by (B) number of neutrophils and (C) myeloperoxidase activity. Metabolic features represented by (D) glucose, (E) triglyceride
and total cholesterol levels, accompanied by the adipocytokines (F) adiponectin and leptin levels in the serum. (G) The PTX3 of mice that received an intra-
articular injection in the knee cavity of PBS, mBSA or mBSA treated prior with RB6-8C5. The bars represent the mean values±SEM (n = 4–6), *P<0.05 vs.
PBS; #P<0.05 vs. AIA of the respective time.
doi:10.1371/journal.pone.0146403.g005
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was associated to insulin resistance, increasing serum levels of glucose and free fatty acids in
humans [30]. However, there is a lack of studies showing the association between pain and
metabolic alterations apart of the context of inflammation.
TNF is a major cytokine in the context of experimental and human arthritis. We showed
that anti-TNF therapy (by using Etanercept) successfully reduced the acute metabolic changes
after AIA in mice. This is consistent with studies showing that anti-TNF therapy improves the
disease and ameliorates the insulin sensibility and lipid levels in RA patients [7, 31]. In rabbits,
activated fibroblast-like synoviocytes are important sources of TNF in antigen-induced arthri-
tis model [32], which could also be the main source of TNF in our model. TNF is a cytokine
involved in the expression of many other cytokines that act in the host defense, and contributes
to the production of acute phase proteins [33, 34]. The PTX3, an acute phase protein, is pro-
duced by leukocytes [18] and its synthesis is induced by cytokines such as TNF and IL-1β [35,
36]. This axis appears to be important to trigger the metabolic changes observed in our study.
In fact, mice treated with anti-TNF showed low levels of PTX3 along with some improvement
on metabolic changes. In addition to contribute to acute inflammation, there are much data
demonstrating that TNF also participates in the resolution of inflammation and tissue remod-
eling [37]. These latter effects of TNF may be relevant in chronic RA patients as tissue remodel-
ing may help adapting to the chronic inflammatory stimulation and chronic metabolic stress.
TNF is also synthesized in the adipose tissue and may act on glucose metabolism through the
increase in lipolysis [38], and consequently contribute to insulin resistance [39]. This cytokine
may also alter the production of adipocytokines, which are involved in the inflammatory process
as well as metabolism [40]. Adiponectin is considered an anti-inflammatory cytokine and is
associated to the insulin sensitivity [41]. Controversially, patients with RA showed an increase
in adiponectin levels that are associated to the disease progression [42]. The decrease in this
cytokine observed in our model may be due to the acute inflammation induced by the arthritis,
yielding the insulin insensitivity. Leptin, which is a pro-inflammatory adipocytokine, is also
increased in RA patients as a predictor of disease duration and development [43]. Although lep-
tin may contribute to the systemic inflammation and consequently metabolic alterations, the
higher levels of this cytokine following AIA may be also a consequence of the acute inflamma-
tory response. Indeed, recent findings showed that leptin secretion from the adipose tissue is
induced few hours after LPS i.p. injection [37]. Combined, these data suggest that metabolic
changes appear to be linked to the acute increase of pro-inflammatory mediators rather than
neutrophils. Moreover, our data suggest that TNF is a major driver of adipocytokines in the con-
text of acute inflammation. Therefore, it appears that inflammatory mediators are the primary
factor driving systemic metabolic changes in arthritis.
Neutrophils and cytokines have a critical role in the inflammatory response observed in RA
and in different models of arthritis [44, 45]. A possible explanation for the accumulation of
neutrophils in adipose tissue and liver following the challenge into the knee could be related to
soluble mediators released by joint resident cells, such as TNF, although we could not detected
it in serum. Moreover, the previously migrated neutrophils into the joint could reach the circu-
lation again [46], a phenomenon called reverse transmigration, which, in turn, could accumu-
late in other organs, as observed in adipose tissue and liver. In the context of RA, the role of
neutrophils is more controversial since these cells are not majority in patients with severe dis-
ease. However, there is evidence that neutrophil influx does occur during recurrence of disease
and may contribute to joint damage [4]. It is known that neutrophils contribute to the produc-
tion of cytokines [47], reactive oxygen species [48] in an acute inflammatory response. Neutro-
phil may also contribute to metabolic changes including insulin resistance and liver steatosis,
induced by obesity [49, 50]. In our experiments, the use of a CXCR1/2 antagonist did not
improve the systemic metabolic alterations observed in AIA mice. However, we did have
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concerns whether these results were due to the presence of some neutrophils still activated in
the circulation. Thus, we depleted neutrophils. Again, the acute systemic metabolic alterations
of AIA mice were still present, even in the absence of neutrophils. Moreover, the levels of PTX3
were even increased after the inhibition of neutrophil recruitment or their depletion. Therefore,
the worsening of some metabolic parameters in AIA mice may be associated to the increase in
systemic inflammatory response that appears to be involved in the production of cytokines.
In summary, our data showed that the induction of local joint inflammation in mice pro-
voked acute alterations in systemic metabolic parameters that were accompanied by an influx
of neutrophils into the adipose tissue and liver. The cytokine TNF appears to significantly con-
tribute to the acute systemic metabolic changes. However, the influx of neutrophils does not
account for the metabolic changes observed after AIA. We suggest that the inflammatory cyto-
kines may be the main factors involved in the improvement of the altered systemic metabolic
parameters induced by anti-TNF therapy.
Supporting Information
S1 Fig. The depletion of neutrophils in the blood of mice treated with RB6-8C5 MAb clone.
Analysis of blood cells in the mice that received an intra-articular injection in the knee cavity of
PBS, mBSA or mBSA treated prior with RB6-8C5. It is represented the absolute number of (A)
total leukocytes and (B) neutrophils. (C) Frequency of total neutrophils (GR1+high CD11b+high)
by flow cytometry. The bars represent the mean values±SEM (n = 4–6). (D) Representative dot
plots of neutrophils as frequency of parent (GR1+high CD11b+high). P<0.05 vs. PBS; #P<0.05
vs. AIA of the respective time.
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